|
Delayed
Bombay S.E.
03:26:13 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 161.40 INR | +0.88% |
|
+6.85% | -5.11% |
| Market Cap | 509M 5.32M 4.65M 4.37M 3.99M 7.48M 7.48M 52.44M 20.23M 260M 19.98M 19.54M 837M | P/E 2025 |
17.4x | P/E 2026 | 5.8x |
|---|---|---|---|---|---|
| Enterprise Value | 476M 4.98M 4.35M 4.09M 3.73M 7.01M 7.01M 49.1M 18.94M 243M 18.7M 18.29M 784M | EV / Sales 2025 |
2.05x | EV / Sales 2026 | 0.85x |
| Free-Float |
33% | Yield 2025 |
0.87% | Yield 2026 | 1.89% |
| 1 day | +0.88% | ||
| 1 week | +6.85% | ||
| Current month | +3.46% | ||
| 1 month | +5.15% | ||
| 3 months | -5.67% | ||
| 6 months | +48.35% | ||
| Current year | -5.11% |
| 1 week | 151.15 |  | 164.95 |
| 1 month | 143.05 | | 164.95 |
| Current year | 100.1 | | 188 |
| 1 year | 100.1 | | 220 |
| 3 years | 100.1 | | 398 |
| 5 years | 97.4 | | 398 |
| 10 years | 21.5 | | 398 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajesh Pokerna
CEO | Chief Executive Officer | 61 | 2016-08-20 |
Sunil Kumar Jain
DFI | Director of Finance/CFO | 64 | 2005-10-06 |
| Compliance Officer | - | 2020-08-02 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 2005-12-11 | |
Sunil Kumar Jain
BRD | Director/Board Member | 64 | 2005-10-06 |
Rajesh Pokerna
BRD | Director/Board Member | 61 | 2016-08-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.88% | +6.85% | -13.53% | -14.69% | 5.32M | |
| +0.45% | +3.00% | +55.00% | +112.54% | 1,043B | |
| -0.10% | +0.74% | +54.52% | +67.72% | 649B | |
| +0.28% | +0.82% | +19.15% | +73.63% | 469B | |
| -0.29% | +0.36% | +37.18% | +45.78% | 355B | |
| -0.02% | +2.10% | +19.65% | +26.14% | 270B | |
| -1.10% | +3.68% | +11.76% | +12.40% | 262B | |
| +4.34% | +9.21% | +43.44% | +53.25% | 222B | |
| +1.40% | +4.35% | +35.72% | +103.53% | 189B | |
| -0.53% | -5.37% | -31.11% | -59.52% | 175B | |
| Average | +0.51% | +2.65% | +23.18% | +42.08% | 363.3B | |
| Weighted average by Cap. | +0.32% | +2.19% | +36.94% | +66.98% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 340M 3.56M 3.11M 2.92M 2.66M 5M 5M 35.05M 13.52M 174M 13.35M 13.06M 560M | 357M 3.74M 3.27M 3.07M 2.8M 5.26M 5.26M 36.84M 14.21M 182M 14.03M 13.73M 588M |
| Net income | 42.46M 444K 388K 365K 333K 625K 625K 4.38M 1.69M 21.68M 1.67M 1.63M 69.91M | 57.89M 606K 529K 497K 454K 852K 852K 5.97M 2.3M 29.56M 2.27M 2.22M 95.31M |
| Net Debt | -36.87M -386K -337K -317K -289K -543K -543K -3.8M -1.47M -18.83M -1.45M -1.42M -60.7M | -32.39M -339K -296K -278K -254K -477K -477K -3.34M -1.29M -16.54M -1.27M -1.24M -53.33M |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-23 | ₹161.40 | +0.88% | 505 |
| 26-09-22 | ₹160.00 | +3.46% | 653 |
| 26-09-21 | ₹154.65 | -1.59% | 1,996 |
| 26-09-18 | ₹157.15 | -0.16% | 2,583 |
| 26-09-17 | ₹157.40 | +4.20% | 2,026 |
- Stock Market
- Stocks
- VRL6 Stock
Select your edition
All financial news and data tailored to specific country editions
